GE Healthcare Deploys Remote Patient Data Monitoring Technology to Help Clinicians Support Most Critical COVID-19 Patients across the Health System

Scaled using Microsoft Azure, GE Healthcare’s Mural Virtual Care Solution allows clinicians to view numerous ventilated patients simultaneously and remotely; enables early identification of patients at risk of deterioration CHICAGO – April 15, 2020 – GE Healthcare today introduced a new software solution to support clinicians and health systems in the treatment of COVID-19 patients.... Read more

PerkinElmer Launches Solutions to Streamline Analysis for Labs in Pharmaceuticals, Semiconductors, Biomonitoring, Food and Materials

Multi-Quadrupole ICP-MS, FT-IR and automation innovations provide testing and research performance, flexibility and ease of use WALTHAM, Mass. – April 15, 2020 – PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today expanded its analysis and automation portfolio for quality, safety and content testing. Geared for pharmaceutical, semiconductor, biomonitoring, food, materials... Read more

EDAX Releases New APEX Software for EDS and EBSD

Wednesday, April 15, 2020 JOIN THE CONVERSATION MAHWAH, NJ, April 15, 2020 – EDAX, Inc., a leader in X-ray microanalysis and electron diffraction instrumentation, has introduced the latest version of its APEX™ software for integrated Energy Dispersive Spectroscopy (EDS)-Electron Backscatter Diffraction (EBSD) applications. APEX™ 2.0 gives users the ability to collect and analyze simultaneous EDS and... Read more

Oxford Instruments partners with Direct Electron in Europe

14 Apr Oxford Instruments plc, a leading provider of high technology products and services to industrial companies and scientific research communities, is pleased to announce that its NanoAnalysis division has recently partnered with US-based Direct Electron who produce next-generation direct detection cameras for Transmission Electron Microscopes (TEM). NanoAnalysis will act on behalf of Direct Electron... Read more

An Overview of 3D X-ray Microscopy

ZEISS and Wiley present free guide X-ray microscopy (XRM) can deliver high resolution and contrast in three dimensions, and can do so without destroying samples. This Essential Knowledge Briefing (EKB) reviews the latest in XRM technology and presents some different application examples in the fields of additive manufacturing, batteries, crystallography, biomaterials and semiconductors. Click here... Read more

Bruker Highlights New Analytical Systems and Applied Market Solutions

BILLERICA, Mass.–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) this week highlights new analytical systems and high-value solutions for biopharma and forensics applications, as well as for industrial process control and materials science research. Originally, Bruker had planned to launch these products at Analytica 2020 this week. However, with conferences and tradeshows postponed or cancelled due to... Read more

EUROIMMUN is one of first European manufacturers of diagnostic tests to provide CE-marked antibody detection systems to support COVID-19 diagnostics

The Anti-SARS-CoV-2 ELISAs for immunoglobulin classes A and G from EUROIMMUN, a PerkinElmer, Inc.  company (NYSE:PKI), have received the CE mark and can now be applied to COVID-19 diagnostics. The PCR test EURORealTime SARS-CoV-2 has been submitted for CE mark. COVID-19 is currently significantly affecting the lives of people worldwide. At the end of January... Read more

Statement from GE Healthcare President & CEO on Efforts to Address the Coronavirus

CHICAGO – March 19, 2020 – GE Healthcare President & CEO Kieran Murphy today issued the following statement around efforts to address the coronavirus (COVID-19): “GE Healthcare is proud to support customers, governments and the broader healthcare community in the fight against the coronavirus https://www.ge.com/news/press-releases/statement-ge-healthcare-president-ceo-efforts-address-coronavirus Read more

Roche initiates Phase III clinical trial of Actemra/RoActemra in hospitalised patients with severe COVID-19 pneumonia

Basel, 19 March 2020- Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced  we are working with the Food & Drug Administration (FDA) to initiate a randomised, double-blind, placebo-controlled Phase III clinical trial in collaboration with the Biomedical Advanced Research and Development Authority (BARDA), a part of the US Health and Human Services Office of the... Read more